Shufeng Liu
- Epidemiology top 5%
- Infectious Diseases top 5%
- Hepatology top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Co-authors
- Tony T. WangWei YangTianyi WangJerrold R. TurnerLe ShenCarolyn B. CoyneLeon J. DeLalioBrant E. Isakson
- Topics
- SARS-CoV-2 and COVID-19 Research (16 papers)Hepatitis C virus research (10 papers)COVID-19 Clinical Research Studies (9 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Shufeng Liu
56 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Epidemiology 611
- Infectious Diseases 541
- Hepatology 417
- Cardiology and Cardiovascular Medicine 376
- Molecular Biology 365
Countries citing papers authored by Shufeng Liu
This map shows the geographic impact of Shufeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufeng Liu more than expected).
Fields of papers citing papers by Shufeng Liu
This network shows the impact of papers produced by Shufeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufeng Liu. The network helps show where Shufeng Liu may publish in the future.
Co-authorship network of co-authors of Shufeng Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Shufeng Liu. A scholar is included among the top collaborators of Shufeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufeng Liu. Shufeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 11 | |
| 5 | 15 | |
| 6 | 35 | |
| 7 | 2 | |
| 8 | 18 | |
| 9 | 75 | |
| 10 | 7 | |
| 11 | 38 | |
| 12 | 5 | |
| 13 | 32 | |
| 14 | 36 | |
| 15 | 29 | |
| 16 | 37 | |
| 17 | 50 | |
| 18 | 17 | |
| 19 | 39 | |
| 20 | 40 |
About Shufeng Liu
Shufeng Liu is a scholar working on Hepatology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 62 papers that have together received 1.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (16 papers), Hepatitis C virus research (10 papers) and COVID-19 Clinical Research Studies (9 papers). The work is most often cited by research in Hepatology (417 citations), Infectious Diseases (541 citations) and Epidemiology (611 citations). Shufeng Liu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Tony T. Wang, Wei Yang, Tianyi Wang, Jerrold R. Turner, Le Shen, Carolyn B. Coyne, Leon J. DeLalio, Brant E. Isakson, Simon C. Watkins and Paul Ziegler. Their work appears in journals such as Journal of the American Chemical Society, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.